NCT06327035 Evolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center
| NCT ID | NCT06327035 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinique Les Trois Soleils |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-03-26 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-03-26 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to describe the evolution of gait recovery during the subacute phase of stroke up to six months after stroke, in patients hospitalized in medical and neurological rehabilitation units.
Eligibility Criteria
Inclusion Criteria: * Patient hospitalized in one of the investigating centers after acute/subacute stroke. * Affiliated to a social security scheme Exclusion Criteria: * Opposed to its participation in this study * Neurodegenerative disease impacting gait prior to stroke onset * Patient not walking before stroke * Progressive pathology with life-threatening consequences within 6 months * Patient under legal protection
Contact & Investigator
Christophe T Duret, MD
PRINCIPAL INVESTIGATOR
Les Trois Soleils
Frequently Asked Questions
Who can join the NCT06327035 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06327035 currently recruiting?
Yes, NCT06327035 is actively recruiting participants. Contact the research team at ag.grosmaire@les-trois-soleils.fr for enrollment information.
Where is the NCT06327035 trial being conducted?
This trial is being conducted at Granville, France, Boissise-le-Roi, France, Boissise-le-Roi, France.
Who is sponsoring the NCT06327035 clinical trial?
NCT06327035 is sponsored by Clinique Les Trois Soleils. The principal investigator is Christophe T Duret, MD at Les Trois Soleils. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.